NewslettersHuman Immunology NewsUncategorizedTargeting Myeloid Derived Suppressor Cells Reverts Immune Suppression and Sensitizes BRAF-Mutant Papillary Thyroid Cancer to MAPK InhibitorsBy Justin.choi - March 29, 20220100Scientists demonstrated that BRAFV600E promoted thyroid cancer development by increasing myeloid-derived suppressor cells penetrance.[Nature Communications] 6445212 AAAAAAAA items 1 apa 0 default asc 1 173401 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article